Allogeneic double-negative T cell therapy for relapsed acute myeloid leukemia patients post allogeneic hematopoietic stem cell transplantation: A first-in-human phase I study
Am. J. Hematol., First published: 06 April 2022 | https://doi.org/10.1002/ajh.26564